Sort
48,018 grants matching “immunotherapy”
Molecular mechanisms for antiviral signaling and regulation by MDA5 and TRIM65
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2023 · AI
Outreach Core
$442,500Wesley Tansey · Sloan-Kettering Inst Can Research · U54 · FY2025 · CA
Project III: Engineering immunogenic cell death in melanoma and renal cell carcinoma.
$442,500Emily H Cheng · Sloan-Kettering Inst Can Research · U54 · FY2025 · CA
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-I
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2017 · AI
Control of Airway Tolerance
$442,500Michael Croft · La Jolla Institute For Immunology · R01 · FY2015 · AI
Molecular mechanisms for antiviral signaling and regulation by MDA5 and TRIM65
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2024 · AI
Structural and functional analyses of the RIG-I filament in innate immunity
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2016 · AI
Molecular mechanisms for antiviral signaling and regulation by MDA5 and TRIM65
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2020 · AI
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-I
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2016 · AI
Project II: Immune regulatory circuits in primary colon cancer and lymph node and liver metastases
$442,500Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2025 · CA
Ultrasound imaging and enhanced therapeutic response
$442,475Katherine W Ferrara · University Of California At Davis · R01 · FY2014 · CA
Immune regulation to Coccidioides infection
$442,470Katrina K Hoyer · University Of California, Merced · R15 · FY2023 · AI
Combining AD Epitope Vaccine with Innate Immunity
$442,458David Hastings Cribbs · University Of California-Irvine · R01 · FY2010 · NS
Macrophage mitochodrial reprogramming and innate immune memory
$442,368Edward R Sherwood · Vanderbilt University Medical Center · R01 · FY2020 · AI
Therapeutic targeting of the tumor microenvironment in triple negative breast cancer patients at high risk of relapse and preclinical models of lung metastases
$442,343Linda Theresa Vahdat · Dartmouth-Hitchcock Clinic · R01 · FY2025 · CA
Structural and functional analyses of the RIG-I filament in innate immunity
$442,292Sun Hur · Boston Children'S Hospital · R01 · FY2015 · AI
Immune-mediated therapies in a genetically engineered murine model of diffuse intrinsic pontine glioma
$442,283Maria G Castro · University Of Michigan At Ann Arbor · R21 · FY2019 · NS
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$442,270Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2023 · NS
Targeting melanoma promoting RNA modification pathway for melanoma therapy.
$442,236Narendra Wajapeyee · University Of Alabama At Birmingham · R01 · FY2025 · CA
Cellular Processing Core
$442,231Ian McNiece · Johns Hopkins University · P01 · FY2007 · CA
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
$442,225Paul Michael Armistead · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology
$442,222K. Vinod Vijayan · Baylor College Of Medicine · R01 · FY2021 · CA
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
$442,221Andrea Facciabene · University Of Pennsylvania · R01 · FY2021 · CA
Mechanisms by which effector T cells modulate endogenous remyelination
$442,217Peter A Calabresi · Johns Hopkins University · R01 · FY2025 · NS
Targeting MUC1-C with an antibody drug conjugate for the therapy of advanced prostate cancer
$442,214Donald W. Kufe · Dana-Farber Cancer Inst · R21 · FY2022 · CA